Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 187,028 $ 187,353
Short-term restricted cash 1,105 982
Short-term investments 14,612 18,529
Accounts receivable, net 158,232 170,971
Inventory 114,942 160,544
Prepaid expenses and other current assets 32,688 24,745
Total current assets 508,607 563,124
Long-term restricted cash 19 22
Property and equipment, net 69,484 79,018
Leased right-of-use assets 32,647 28,515
Intangible assets, net 82,643 109,316
Goodwill 318,456 306,739
Deferred tax assets 59,121 66,491
Other long-term assets 32,810 26,800
Total assets 1,103,787 1,180,025
Current liabilities:    
Accounts payable 45,203 68,576
Accrued price protection liability 71,643 113,274
Accrued expenses and other current liabilities 86,276 100,155
Accrued compensation 29,788 59,081
Total current liabilities 232,910 341,086
Long-term lease liabilities 28,017 23,353
Long-term debt 122,219 121,757
Other long-term liabilities 17,964 17,444
Total liabilities 401,110 503,640
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 81,561 shares issued and outstanding at September 30, 2023 and 78,745 shares issued and outstanding December 31, 2022 8 8
Additional paid-in capital 790,634 722,778
Accumulated other comprehensive loss (7,938) (1,021)
Accumulated deficit (80,027) (45,380)
Total stockholders’ equity 702,677 676,385
Total liabilities and stockholders’ equity $ 1,103,787 $ 1,180,025